ASP Isotopes advances Renergen acquisition after compliance approval

Claim 50% Off TipRanks Premium and Invest with Confidence Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potentialASP Isotopes, Inc. ( (ASPI) ) has provided an announcement. On December 18, 2025, ASP Isotopes Inc. confirmed that South Africa’s Takeover Regulation Panel had issued a compliance certificate for its scheme of arrangement to acquire all issued ordinary shares of Renergen Limited, under which Renergen shareholders would receive 0.09196 new ASP Isotopes shares for each Renergen share, allowing the transaction to proceed toward implementation. The timetable sets out key milestones through mid‑January 2026, including suspension and eventual termination of Renergen’s listings on the JSE, A2X and ASX, the listing and settlement of new ASP Isotopes shares to former Renergen shareholders in South Africa and Australia, and the handling of fractional cash entitlements, underscoring the complexity of the cross‑border settlement structure and marking a significant step in ASP Isotopes’ expansion via the full acquisition and delisting of Renergen. The most recent analyst rating on (ASPI) stock is a Hold with a $6.00 price target. To see the full list of analyst forecasts on ASP Isotopes, Inc. stock, see the ASPI Stock Forecast page. Spark’s Take on ASPI Stock According to Spark, TipRanks’ AI Analyst, ASPI is a Neutral. ASP Isotopes, Inc. faces significant financial and technical challenges, with high leverage and negative profitability impacting its financial health. The stock’s bearish technical indicators further weigh on its outlook. However, recent corporate events and a balanced earnings call provide some positive momentum. The overall score reflects the need for improved operational efficiency and financial management. To see Spark’s full report on ASPI stock, click here. More about ASP Isotopes, Inc. ASP Isotopes Inc. operates in the isotope production and related technologies sector, focusing on the development and supply of specialized isotopes for industrial, medical and energy applications, with a strategy that includes cross-border transactions and listings in multiple markets to broaden its investor base and strengthen its presence in the global resources and technology value chain. Average Trading Volume: 8,005,758 Technical Sentiment Signal: Sell Current Market Cap: $630.7M Learn more about ASPI stock on TipRanks’ Stock Analysis page.